PMID- 27852823 OWN - NLM STAT- MEDLINE DCOM- 20170605 LR - 20220317 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 292 IP - 4 DP - 2017 Jan 27 TI - Phosphorylation of Human Retinoid X Receptor alpha at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1alpha,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes. PG - 1490-1509 LID - 10.1074/jbc.M116.758185 [doi] AB - Human retinoid X receptor alpha (hRXRalpha) plays a critical role in DNA binding and transcriptional activity through heterodimeric association with several members of the nuclear receptor superfamily, including the human vitamin D receptor (hVDR). We previously showed that hRXRalpha phosphorylation at serine 260 through the Ras-Raf-MAPK ERK1/2 activation is responsible for resistance to the growth inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) (1alpha,25(OH)(2)D(3)), the biologically active metabolite of vitamin D(3) To further investigate the mechanism of this resistance, we studied intranuclear dynamics of hVDR and hRXRalpha-tagged constructs in living cells together with endogenous and tagged protein in fixed cells. We find that hVDR-, hRXRalpha-, and hVDR-hRXRalpha complex accumulate in the nucleus in 1alpha,25(OH)(2)D(3)-treated HPK1A cells but to a lesser extent in HPK1ARas-treated cells. Also, by using fluorescence resonance energy transfer (FRET), we demonstrate increased interaction of the hVDR-hRXRalpha complex in 1alpha,25(OH)(2)D(3)-treated HPK1A but not HPK1ARas cells. In HPK1ARas cells, 1alpha,25(OH)(2)D(3)-induced nuclear localization and interaction of hRXRalpha are restored when cells are treated with the MEK1/2 inhibitor UO126 or following transfection of the non-phosphorylatable hRXRalpha Ala-260 mutant. Finally, we demonstrate using fluorescence loss in photobleaching and quantitative co-localization with chromatin that RXR immobilization and co-localization with chromatin are significantly increased in 1alpha,25(OH)(2)D(3)-treated HPK1ARas cells transfected with the non-phosphorylatable hRXRalpha Ala-260 mutant. This suggests that hRXRalpha phosphorylation significantly disrupts its nuclear localization, interaction with VDR, intra-nuclear trafficking, and binding to chromatin of the hVDR-hRXR complex. CI - (c) 2017 by The American Society for Biochemistry and Molecular Biology, Inc. FAU - Jusu, Sylvester AU - Jusu S AD - From the Department of Medicine, Calcium Research Laboratory, Royal Victoria Hospital, McGill University, Montreal, Quebec H4A 3J1. AD - the Department of Medicine, Experimental Therapeutics and Metabolism Program, McGill University Health Center, Montreal, Quebec H4A 3J1, Canada. FAU - Presley, John F AU - Presley JF AD - the Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec H3A 0C7, and. FAU - Kremer, Richard AU - Kremer R AD - From the Department of Medicine, Calcium Research Laboratory, Royal Victoria Hospital, McGill University, Montreal, Quebec H4A 3J1, richard.kremer@mcgill.ca. AD - the Department of Medicine, Experimental Therapeutics and Metabolism Program, McGill University Health Center, Montreal, Quebec H4A 3J1, Canada. LA - eng GR - MOP10839/CIHR/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20161116 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Retinoid X Receptor alpha) RN - 452VLY9402 (Serine) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - EC 3.6.5.2 (ras Proteins) RN - FXC9231JVH (Calcitriol) SB - IM MH - Active Transport, Cell Nucleus/drug effects MH - Amino Acid Substitution MH - Calcitriol/*pharmacology MH - Cell Line, Transformed MH - Cell Nucleus/genetics/*metabolism MH - Extracellular Signal-Regulated MAP Kinases/genetics/metabolism MH - Humans MH - Keratinocytes/*metabolism MH - Mutation, Missense MH - Phosphorylation/drug effects/genetics MH - Retinoid X Receptor alpha/genetics/*metabolism MH - Serine MH - ras Proteins/genetics/metabolism PMC - PMC5270490 OTO - NOTNLM OT - fluorescence loss in photobleaching (FLIP) OT - fluorescence resonance energy transfer (FRET) OT - mitogen-activated protein kinase (MAPK) OT - phosphorylation OT - retinoid OT - retinoid X receptor OT - vitamin D OT - vitamin D receptor EDAT- 2016/11/18 06:00 MHDA- 2017/06/06 06:00 PMCR- 2018/01/27 CRDT- 2016/11/18 06:00 PHST- 2016/09/12 00:00 [received] PHST- 2016/10/14 00:00 [revised] PHST- 2016/11/18 06:00 [pubmed] PHST- 2017/06/06 06:00 [medline] PHST- 2016/11/18 06:00 [entrez] PHST- 2018/01/27 00:00 [pmc-release] AID - S0021-9258(20)32131-1 [pii] AID - M116.758185 [pii] AID - 10.1074/jbc.M116.758185 [doi] PST - ppublish SO - J Biol Chem. 2017 Jan 27;292(4):1490-1509. doi: 10.1074/jbc.M116.758185. Epub 2016 Nov 16.